224 related articles for article (PubMed ID: 8871970)
1. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
Dorta-Contreras A; Silva-Somoza R
Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid and serum antiphospholipid antibodies in multiple sclerosis, Guillain-Barré syndrome and systemic lupus erythematosus.
Marchiori PE; Dos Reis M; Quevedo ME; Callegaro D; Hirata MT; Scaff M; De Oliveira RM
Arq Neuropsiquiatr; 1990 Dec; 48(4):465-8. PubMed ID: 2094193
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
Sharief MK; McLean B; Thompson EJ
Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
7. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
8. Protein pattern of cerebrospinal fluid in various neurological diseases.
Hornig CR; Busse O; Dorndorf W
Arch Psychiatr Nervenkr (1970); 1983; 233(3):253-62. PubMed ID: 6615190
[TBL] [Abstract][Full Text] [Related]
9. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
Holmøy T; Vandvik B; Vartdal F
Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
[TBL] [Abstract][Full Text] [Related]
10. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
[TBL] [Abstract][Full Text] [Related]
11. [Changes in cerebrospinal fluid immunoglobulin serial parameters in neurologic disorders].
Wang WZ; Zhou YK
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):12-6, 61. PubMed ID: 2805971
[TBL] [Abstract][Full Text] [Related]
12. Protein gradients in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis.
Wurster U
J Neuroimmunol; 1988 Dec; 20(2-3):233-5. PubMed ID: 3198747
[TBL] [Abstract][Full Text] [Related]
13. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
Vedeler CA; Matre R; Sadallah S; Schifferli J
J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
[TBL] [Abstract][Full Text] [Related]
14. Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome.
Araga S; Kagimoto H; Adachi A; Funamoto K; Inoue K; Takahashi K
Jpn J Med; 1991; 30(2):118-22. PubMed ID: 1907691
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
Matà S; Lolli F; Söderström M; Pinto F; Link H
Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
[TBL] [Abstract][Full Text] [Related]
17. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases.
Suchanek G; Kristoferitsch W; Stanek G; Bernheimer H
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):160-8. PubMed ID: 3577478
[TBL] [Abstract][Full Text] [Related]
18. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
Shimada K; Koh CS; Yanagisawa N
Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
[TBL] [Abstract][Full Text] [Related]
19. An ultrasensitive method for the detection of oligoclonal IgG bands.
Sádaba MC; González Porqué P; Masjuan J; Alvarez-Cermeño JC; Bootello A; Villar LM
J Immunol Methods; 2004 Jan; 284(1-2):141-5. PubMed ID: 14736424
[TBL] [Abstract][Full Text] [Related]
20. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
